colfax fluid handling is a world leader in the development, engineering, manufacturing, distribution, service and support of pumping and fluid-handling systems. specializing in positive displacement and centrifugal technologies, our products support a wide range of industries, from power generation and oil & gas to commercial and navy marine to a broad range of industrial applications. for over 10 years, colfax fluid handling has remained at the forefront of fluid-handling management by focusing on customer needs for precision performance around the world with a portfolio of pump products, deep expertise in critical applications, strong global resources and a company-wide commitment to excellence through processes such as the colfax business system. colfax brings together brands that have led their markets throughout the americas, europe, the middle east, africa and asia/pacific for decades. through its allweiler, houttuin, imo, portland valve, tushaco, warren, and zenith products, c
Company profile
Ticker
ENOV
Exchange
Website
CEO
Matthew Trerotola
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Colfax CORP
SEC CIK
Corporate docs
Subsidiaries
360 EPPA Pty Ltd • 360 Hip Systems Pty Limited • 360 Knee Systems (NZ) Limited • 360 Knee Systems Pty Ltd • 360 Med Care Pty Ltd • Aevumed, Inc. • Athena Finance Limited • BrainScope Company, Inc. • Cefar-Compex Medical AB • Chattanooga Europe, B.V. ...
IRS number
541887631
ENOV stock data
Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEF 14A
Definitive proxy
5 Apr 24
PRE 14A
Preliminary proxy
25 Mar 24
S-3ASR
Automatic shelf registration
22 Feb 24
10-K
2023 FY
Annual report
22 Feb 24
8-K
Enovis Announces Fourth Quarter and Full Year 2023 Results
22 Feb 24
8-K/A
Consolidated financial statements restated as at 31 December 2022
21 Feb 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Enovis Completes Acquisition of LimaCorporate S.p.A
3 Jan 24
8-K
Enovis Announces Business Segment Leadership Transition Plan
5 Dec 23
Transcripts
ENOV
Earnings call transcript
2023 Q4
22 Feb 24
ENOV
Earnings call transcript
2023 Q3
7 Nov 23
ENOV
Earnings call transcript
2023 Q2
3 Aug 23
ENOV
Earnings call transcript
2023 Q1
4 May 23
ENOV
Earnings call transcript
2023 Q1
4 May 23
ENOV
Earnings call transcript
2022 Q4
23 Feb 23
ENOV
Earnings call transcript
2022 Q3
2 Nov 22
ENOV
Earnings call transcript
2022 Q2
6 Aug 22
ENOV
Earnings call transcript
2022 Q1
10 May 22
ENOV
Earnings call transcript
2021 Q4
22 Feb 22
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Oct 21 | Jul 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 32.13 mm | 32.13 mm | 32.13 mm | 32.13 mm | 32.13 mm | 32.13 mm |
Cash burn (monthly) | 120.67 k | 1.90 mm | 8.50 mm | 8.58 mm | (no burn) | (no burn) |
Cash used (since last report) | 806.09 k | 12.71 mm | 56.79 mm | 57.32 mm | n/a | n/a |
Cash remaining | 31.32 mm | 19.42 mm | -24.66 mm | -25.19 mm | n/a | n/a |
Runway (months of cash) | 259.6 | 10.2 | -2.9 | -2.9 | n/a | n/a |
Institutional ownership, Q3 2023
98.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 264 |
Opened positions | 43 |
Closed positions | 38 |
Increased positions | 90 |
Reduced positions | 87 |
13F shares | Current |
---|---|
Total value | 2.85 tn |
Total shares | 54.26 mm |
Total puts | 24.12 k |
Total calls | 38.66 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
T. Rowe Price Investment Management | 6.57 mm | $346.77 bn |
BLK Blackrock | 5.34 mm | $281.32 bn |
Vanguard | 4.90 mm | $258.24 bn |
Dimensional Fund Advisors | 3.08 mm | $162.22 bn |
Diamond Hill Capital Management | 2.43 mm | $128.09 bn |
Select Equity | 2.24 mm | $117.86 bn |
Thrivent Financial For Lutherans | 1.81 mm | $95.58 bn |
DAVENPORT & Co | 1.67 mm | $87.99 bn |
STT State Street | 1.53 mm | $80.58 bn |
Millennium Management | 1.51 mm | $79.41 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Mar 24 | Lalor Angela S | Common stock, par value $0.001 | Grant | Acquire A | No | No | 0 | 361 | 0.00 | 6,776 |
6 Mar 24 | Patricia A Lang | Common stock, par value $0.001 | Payment of exercise | Dispose F | No | No | 61.84 | 718 | 44.40 k | 29,961 |
6 Mar 24 | Trerotola Matthew L. | Common stock, par value $0.001 | Payment of exercise | Dispose F | No | No | 61.84 | 6,157 | 380.75 k | 270,074 |
4 Mar 24 | Phillip Benjamin | Common stock, par value $0.001 | Grant | Acquire A | No | No | 0 | 16,534 | 0.00 | 35,855 |
4 Mar 24 | John Kleckner | Common stock, par value $0.001 | Grant | Acquire A | No | No | 0 | 2,966 | 0.00 | 6,713 |
4 Mar 24 | Patricia A Lang | Common stock, par value $0.001 | Grant | Acquire A | No | No | 0 | 9,507 | 0.00 | 30,679 |
4 Mar 24 | Trerotola Matthew L. | Common stock, par value $0.001 | Grant | Acquire A | No | No | 0 | 64,484 | 0.00 | 276,231 |
News
Banzai Welcomes Over 580 New Customers In Q1, A Quarterly Increase Of 46%
16 Apr 24
Needham Reiterates Buy on Enovis, Maintains $82 Price Target
10 Apr 24
Canaccord Genuity Maintains Buy on Enovis, Raises Price Target to $75
23 Feb 24
Needham Maintains Buy on Enovis, Raises Price Target to $82
23 Feb 24
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact
22 Feb 24
Press releases
NorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers
27 Feb 24
Enovis Announces Fourth Quarter and Full Year 2023 Results
22 Feb 24
Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
12 Feb 24
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
26 Jan 24